Long-acting β2-adrenoceptor agonists: increased risk of death?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1072卷 / 1期
关键词：
Asthma; Advisory Committee; Interim Analysis; Salmeterol; Formoterol;
D O I：
10.2165/00128415-200510720-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] Long-acting β2-adrenoceptor agonists for asthma and COPDLangwirksame β2-Sympathikomimetika in der Behandlung von Asthma bronchiale und COPD
    Klaus F. Rabe
    Dieter Ukena
    Helgo Magnussen
    Medizinische Klinik, 1997, 92 (Suppl 5) : 44 - 49
  • [32] Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
    Beier, Jutta
    Beeh, Kai M.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2011, 6 : 237 - 243
  • [33] β-Adrenoceptor Genotype and Bronchoprotective Subsensitivity with Long-Acting β-Agonists in Asthma
    Lipworth, Brian
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (12) : 1386 - 1387
  • [34] Metabolism and Disposition of Vilanterol, a Long-Acting β2-Adrenoceptor Agonist for Inhalation Use in Humans
    Harrell, Andrew W.
    Siederer, Sarah K.
    Bal, Jo
    Patel, Nainesh H.
    Young, Graeme C.
    Felgate, Clive C.
    Pearce, Sebastian J.
    Roberts, Andy D.
    Beaumont, Claire
    Emmons, Amanda J.
    Pereira, Adrian I.
    Kempsford, Rodger D.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (01) : 89 - 100
  • [35] Ultra-long-acting β2-adrenoceptor agonists -: An emerging therapeutic option for asthma and COPD?
    Matera, Maria Gabriella
    Cazzola, Mario
    DRUGS, 2007, 67 (04) : 503 - 515
  • [36] Inflammatory Stimuli Inhibit Glucocorticoid-Dependent Transactivation in Human Pulmonary Epithelial Cells: Rescue by Long-Acting β2-Adrenoceptor Agonists
    Rider, Christopher F.
    King, Elizabeth M.
    Holden, Neil S.
    Giembycz, Mark A.
    Newton, Robert
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (03): : 860 - 869
  • [37] The discovery of indole-derived long acting β2-adrenoceptor agonists for the treatment of asthma and COPD
    Brown, Alan D.
    Bunnage, Mark E.
    Glossop, Paul A.
    Holbrook, Mark
    Jones, Rhys D.
    Lane, Charlotte A. L.
    Lewthwaite, Russell A.
    Mantell, Simon
    Perros-Huguet, Christelle
    Price, David A.
    Webster, Rob
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6188 - 6191
  • [38] A Holy Grail of asthma management:: toward understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
    Giembycz, M. A.
    Kaur, M.
    Leigh, R.
    Newton, R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (06) : 1090 - 1104
  • [39] Induction of Regulator of G-Protein Signaling 2 Expression by Long-Acting β2-Adrenoceptor Agonists and Glucocorticoids in Human Airway Epithelial Cellss
    Holden, Neil S.
    George, Tresa
    Rider, Christopher F.
    Chandrasekhar, Ambika
    Shah, Suharsh
    Kaur, Manminder
    Johnson, Malcolm
    Siderovski, David P.
    Leigh, Richard
    Giembycz, Mark A.
    Newton, Robert
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (01): : 12 - 24
  • [40] Long-acting β-agonists not linked to increased respiratory deaths
    Reactions Weekly, 2008, 1202 (1) : 1 - 1
12345